Besides following our news, follow us on socials networks :
TransCure bioServices hires Olivier BAVEREY – Business Development Director
TransCure is proud to serve researchers in the field by providing suitable HIV mouse disease models.
Find more about how TransCure improves immuno-oncology research with its humanized mouse model.
TransCure bioServices improves animal health and wellbeing by using microchip-based identification system in order to deliver the best quality data to the customers.
TransCure bioServices shares with you its major achievements in 2018 and its objectives 2019.
Targovax demonstrates the “Synergistic effect of oncolytic virus combined with anti-PD-1 against Melanoma”. TransCure’s hu-mouse are the preferred in vivo models for combination therapy evaluation.